DEFA14A: BlackRock Capital Allocation Term Trust Faces Activist Challenge from Saba Capital

Sentiment:

Proxy Statement


BlackRock Capital Allocation Term Trust (BCAT) urges shareholders to vote against Saba Capital's proposal to replace BlackRock as the investment advisor and install its own board members.

Better than expectedThe fund's returns outperformed a large percentage of closed-end funds in both 2023 and year-to-date 2024.

Summary

  • BlackRock Capital Allocation Term Trust (BCAT) is asking shareholders to vote against a proposal by Saba Capital Management L.P. to terminate BlackRock as the fund's investment advisor.
  • Saba is attempting to install its own board members, which BCAT argues could change the fund's strategy and income stability.
  • BCAT highlights its outperformance, with a 19% return on market price in 2023 and 14% year-to-date in 2024, exceeding the majority of closed-end funds.
  • The fund emphasizes its monthly distributions and a 9.2% yield on market price, which is reportedly seven times higher than US equities.
  • BlackRock emphasizes its expertise, citing Rick Rieder's recognition as Morningstar's Outstanding Portfolio Manager of the Year in 2023 and access to a global team of over 450 investment professionals.
  • BCAT has voluntarily repurchased over $78 million of shares, adding approximately $13 million to its net asset value since inception.
  • The fund uses a managed distribution plan to support a level distribution of income, capital gains, and/or return of capital.
  • For the fiscal year through March 28, 2024, the estimated allocation for BCAT's distribution is $0.382500, entirely from return of capital.
  • The fund's average annual total return (in relation to NAV) for the 5-year period ending on 2/29/2024 was 3.94%, with an annualized current distribution rate of 8.72%.

Sentiment

Score: 7

Explanation: The document conveys a moderately positive sentiment, highlighting the fund's outperformance and high yield, but also acknowledging the challenge from an activist investor. The positive metrics are strong, but the activist threat introduces uncertainty.

Positives

  • BCAT has demonstrated strong performance, outperforming a significant portion of closed-end funds in both 2023 and 2024.
  • The fund offers a high yield on market price through monthly distributions.
  • BlackRock brings significant expertise and resources to managing the fund.
  • Share repurchases have added value to the fund's net asset value.
  • The fund has adopted a managed distribution plan to support a level distribution.

Negatives

  • Saba Capital's attempt to replace BlackRock as the investment advisor creates uncertainty.
  • The estimated allocation for BCAT's distribution for the fiscal year through March 28, 2024, is entirely from return of capital, which may not reflect investment performance.
  • The fund's average annual total return (in relation to NAV) for the 5-year period ending on 2/29/2024 was 3.94%, which may be considered low by some investors.

Risks

  • The potential change in investment advisor and board members could alter the fund's strategy and income stability.
  • Reliance on return of capital for distributions may not be sustainable in the long term.
  • Market fluctuations could impact the fund's net asset value and distribution rate.

Future Outlook

The future of the fund depends on the outcome of the shareholder vote regarding the investment advisor and board members.

Management Comments

  • BlackRock is asking all BCAT shareholders to make their voices heard and protect their investment.
  • An activist hedge fund, Saba, is trying to fire BlackRock as your Funds investment advisor and install its own Board members, which may potentially change your Funds strategy and its ability to deliver the consistent, stable income you rely on.

Industry Context

Activist investors targeting closed-end funds is a recurring theme in the investment management industry, as they seek to unlock value or influence fund strategy.

Comparison to Industry Standards

  • The document states that BCAT's 2023 market price return of 19% outperformed 82% of all closed-end funds.
  • The document states that BCAT's year-to-date 2024 market price return of 14% outperformed 94% of all closed-end funds.
  • The document states that BCAT's distribution yield is 7X higher than US Equities, as represented by the dividend yield of the S&P 500 Index.

Stakeholder Impact

  • Shareholders are directly impacted by the outcome of the vote, which will determine the fund's investment advisor and board members.
  • The fund's strategy and income stability could be affected by the change in management.

Next Steps

  • Shareholders need to vote on the enclosed white proxy card.
  • The Annual Meeting will be held on June 26.

Key Dates

DateDescription
March 28, 2024Date for estimated allocations of fund distributions.
March 31, 2024Morningstar and BlackRock data reference date.
February 29, 2024Date for fund performance and distribution rate information.
May 2024Document publication date.
June 26Date of the upcoming Annual Meeting.

Keywords

BlackRock Capital Allocation Term Trust, BCAT, Saba Capital, Activist Hedge Fund, Proxy Fight, Investment Advisor, Board Nominees, Shareholder Vote, Closed-End Fund, Distributions, Return of Capital, Managed Distribution Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.